"Gasping": Scientists Make Breakthrough Toward Full Cure for HIV

Researchers say they've taken a major step toward finding a cure for HIV.
As The Guardian reports, scientists at the Peter Doherty Institute for Infection and Immunity in Melbourne found a way to make the HIV virus visible, potentially laying the groundwork for ways to banish it from the body altogether.
As detailed in a paper published in the journal Nature Communications, the team developed a way to send messenger RNA into cells, to root out the hiding virus by fully enveloping it in a bubble of formulated fat called lipid nanoparticles (LNPs). The genetic molecules then instruct the cells to make the virus visible.
Author and Doherty Institute research fellow Paula Cevaal told the Guardian that it was "previously thought impossible" to deliver mRNA into HIV-containing white blood cells. But thanks to a new type of LNPs, dubbed LNP X, the team found a way for these cells to accept the mRNA.
"Our hope is that this new nanoparticle design could be a new pathway to an HIV cure," she added.
The human immunodeficiency virus attacks the human body's immune system and can lead to deadly AIDS if left untreated. Despite decades of research, there's still no effective cure for the disease; though a handful of patients have been fully cured of HIV, the treatments remain brutally complex and expensive.
While the number of people in the United States living with HIV has decreased since 2018, over 39,000 new patients were diagnosed in 2023.
The latest research came with such surprising findings that the team didn't believe it at first.
"We were overwhelmed by how [much of a] night and day difference it was — from not working before, and then all of a sudden it was working. And all of us were just sitting gasping like, 'wow,'" Cevaal told the Guardian.
While it's a promising step in the right direction, scientists still have to figure out whether making the hidden virus visible will cause the body's immune system to deal with it. Other possibilities include developing new ways to combine their findings with other gene therapies to ultimately cure HIV.
Before the latest technique can be used in humans, it would also have to be put through its paces, from animal experiments to human safety trials, a process that could easily take many years.
And Cevaal appears to be realistic about those chances.
"In the field of biomedicine, many things eventually don't make it into the clinic — that is the unfortunate truth; I don't want to paint a prettier picture than what is the reality," she told the Guardian. "But in terms of specifically the field of HIV cure, we have never seen anything close to as good as what we are seeing, in terms of how well we are able to reveal this virus."
"So from that point of view, we're very hopeful that we are also able to see this type of response in an animal, and that we could eventually do this in humans," she added.
Beyond HIV, the researchers are hoping their LNP-based mRNA delivery method could be applied to other diseases as well, including certain types of cancer.
More on HIV: Religious Conservatives Trying to End Insurance Coverage of Incredibly Effective Anti-HIV Drug

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

UPI

8 hours ago

• UPI

NIH office to phase out HIV guidelines by next year

The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS patients in the United States is making major changes. File Photo by Annabelle Gordon/UPI | License Photo June 21 (UPI) -- The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS patients in the United States is making major changes. The NIH Office of AIDS Research or OAR told its employees this week it intends to phase out the guidelines by next June, the Washington Post reported, citing an internal staff email. According to the office, OAR "coordinates HIV/AIDS research across the National Institutes of Health and provides the largest public investment in HIV/AIDS research globally." "In the climate of budget decreases and revised priorities, OAR is beginning to explore options to transfer management of the guidelines to another agency within" the letter obtained by The Post reads. The OAR guidelines contain guidelines related to diagnosis and treatments of HIV and AIDS. There are currently more than 1 million people living with HIV in the United States. It was not immediately clear what the other agency referred to in the letter was or how such a move may affect the guideline, the Post reported. The news comes as President Donald Trump and Secretary of State Marco Rubio move to cut over $8 billion from the U.S. Agency for International Development, USAID and merge it into the State Department. State Department officials say the move comes with the expectation that other countries will increase their roles in delivering aid around the world. An April report published in the Lancet medical journal found around half a million children globally could die from AIDS by 2030 if the United States cuts its global relief funding. Earlier this week, the U.S. Food and Drug Administration approved use of the HIV drug lenacapavir, which is produced by California-based biopharma firm Gilead Sciences under the name Yeztugo. "Yeztugo is one of the most important scientific breakthroughs of our time and offers a very real opportunity to help end the HIV epidemic," Gilead Science Chairman and Chief Executive Officer Daniel O'Day said in a statement on the company's website

Yahoo

13 hours ago

• Yahoo

Experts celebrate as trail cameras capture once-in-a-lifetime photograph of 'forgotten' creature: 'The feeling was unbelievable'

A once-in-a-lifetime photograph of the Upemba lechwe has been published after one of the most endangered African animals momentarily paused for the camera. While the image is fuzzy, it clearly shows the endangered "forgotten antelope" standing in a grassy field — almost as if he's proudly posing for the now-famous photo. "The feeling was unbelievable," said Manuel Weber of the Department of Research and Biomonitoring at Upemba National Park, according to the Guardian. Researchers had feared they might not find any lechwe at all during the survey. But the camera told a different story. The antelope stopped for "literally a few seconds." What makes this photo so special? This sighting marks the first photographic evidence of a living Upemba lechwe since 2005, making it a significant breakthrough for the species and conservation efforts across the region. Experts estimate fewer than 100 Upemba lechwe remain in the wild, which makes every single sighting incredibly valuable. Researchers captured the photo in Upemba National Park, a remote region in the Democratic Republic of the Congo, where lechwe once roamed in far greater numbers. For years, conservationists worried the species might already be lost — wiped out by decades of poaching and habitat destruction. But during a recent aerial survey, researchers spotted one from above and managed to snap a quick photo. It's a small moment but a powerful one. "We hope this image becomes a rallying cry," Weber stated, according to the Guardian. "Because this may be our only chance to save this species." Protecting species like the Upemba lechwe doesn't just help preserve biodiversity — it also supports the livelihoods of nearby communities, bolsters food chains, and strengthens ecosystems that humans depend on. Smart management of our environment ensures more than just wildlife survival — it helps drive progress toward a cleaner, safer future for everyone. Cameras are proving to be powerful tools for scientists. While researchers used an aerial device for this image, conservationists often rely on trail cameras to non-invasively track elusive species and monitor their population health over time. Should the government be able to control how we heat our homes? Definitely Only if it saves money I'm not sure No way Click your choice to see results and speak your mind. Trail cams can also show when things are starting to go right — whether it's a species coming back, new babies being born, or animals returning to old migration paths. It's all proof that careful, thoughtful stewardship of the environment makes a real difference. When we manage habitats wisely, we're not just helping wildlife — we're protecting the systems that grow our food, filter our water, and support our communities. A healthy ecosystem doesn't just benefit the animals in it — it helps people, too. Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet.

Washington Post

16 hours ago

• Washington Post

Administration to phase out NIH support of HIV clinical guidelines

The National Institutes of Health's support for federal guidelines that steer the treatment of more than a million HIV patients in the United States will be phased out by next June, according to the agency's Office of AIDS Research, a move that troubled some doctors and raised questions about whether the guidelines themselves will change. It is unclear whether Health and Human Services Secretary Robert F. Kennedy Jr. plans to bring the guidance in line with his own controversial views about an infectious disease that 30 years ago was the leading cause of death for people 25 to 44 years old. The Office of AIDS Research, which is part of the National Institutes of Health, informed members of the panels responsible for the guidelines in a letter that, 'in the climate of budget decreases and revised priorities, OAR is beginning to explore options to transfer management of the guidelines to another agency within' HHS. The guidelines, detailed recommendations on how to diagnose and treat medical conditions, can affect what tests, treatments and medications are covered by insurance companies and Medicare, said Aniruddha Hazra, associate professor of medicine at University of Chicago Medicine. The lack of clarity in the letter caused some in the medical community to worry that switching oversight of the guidelines to another branch of HHS could be a first step by the Trump administration toward more drastic changes in the government's treatment recommendations. 'From a practical standpoint, it's monumental,' Hazra said of the news about the guidelines, which he called the basis for much of the knowledge about HIV. 'The loss of this kind of federal guidance throws everything into the dark,' he said. Hazra described the guidelines as a dynamic document that changes at least once or twice a year as new studies and scientific evidence come to light. Guidelines for HIV are divided into a half-dozen categories, including sets for adults/adolescents, pediatric patients, pregnant women and HIV patients who are displaced by natural disasters. The webpage listing the guidelines now says they are 'being updated to comply with Executive Orders,' raising the question of whether sections dealing with care for transgender people with HIV may be changed or eliminated. The letter sent to panel members did not say specifically if or how the clinical practice guidelines might change, only that 'Together, we now have an opportunity to develop a proactive, careful transition plan for each Panel.' The letter noted that 'a special session on guidelines sustainability planning' has been scheduled for Thursday with panel leadership and the Office of AIDS Research Advisory Council. Officials at NIH referred questions to the Department of Health and Human Services, which did not respond to emails requesting clarification of the letter. Kennedy has long espoused controversial views about HIV, suggesting that contrary to widely held medical belief, the virus was not the cause of AIDS. In a video posted on Twitter in 2023, Kennedy tells an audience, 'A hundred percent of the people who died at first, the first thousand who had AIDS, were people who were addicted to [a class of drugs called] poppers. … They were people who were part of a gay lifestyle. They were burning the candle at both ends, and they were taking a lot of injectable drugs.' Under Kennedy, HHS has terminated hundreds of millions of dollars in HIV-related research grants. The department closed its Office of Infectious Diseases & HIV Policy that coordinated the federal response to the virus. At the same time, the Centers for Disease Control and Prevention lost staff in its HIV prevention division who conducted studies and surveillance, ran health campaigns and supported local prevention programs. 'These guidelines serve as a reference for the world in addition to caring for people in the U.S.,' said Theodore Ruel, chief of the Division of Pediatric Infectious Diseases and Global Health at UCSF Benioff Children's Hospital, and co-chair of one of the panels responsible for the guidelines. 'It is disappointing that such a key guideline about HIV for children in the USA will no longer be supported by the NIH,' said Ruel — whose panel examines antiretroviral therapy for the medical management of children living with HIV — stressing that he was not speaking for the other panelists. 'I am concerned that we are unlikely to find a new home that can maintain the same depth, quality, access and capacity for real-time updating.' He expressed faith that the panelists would push to find a home for the guidelines where they can continue to offer 'science-driven support' for doctors and patients. James M. Sosman, medical director for UW Health's HIV Care and Prevention Program, who has been caring for people with the disease for decades, said that having the guidelines under the auspices of the Office of AIDS Research made sense. 'Would I look to move that? I'm reluctant because it's like, 'Hey, if you've got a guy that's hitting home runs at third base, don't move them to first base,'' Sosman said. 'I mean if it's working out, why are you disrupting this for costs that don't seem that great.'